|
|
LETTER TO THE EDITOR |
|
Year : 2018 | Volume
: 66
| Issue : 1 | Page : 177-178 |
|
Comment on “Impact of expansion of telemedicine screening for retinopathy of prematurity in India”
T Lalit Agarwal, Kshitij Aditya, Nisha Agrawal, Ichhya Joshi
Vitreo-Retina Department, Biratnagar Eye Hospital, Biratnagar, Nepal
Date of Web Publication | 28-Dec-2017 |
Correspondence Address: Dr. T Lalit Agarwal Vitreo-Retina Department, Biratnagar Eye Hospital, Atithi Marg 17, Biratnagar Nepal
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/ijo.IJO_777_17
How to cite this article: Agarwal T L, Aditya K, Agrawal N, Joshi I. Comment on “Impact of expansion of telemedicine screening for retinopathy of prematurity in India”. Indian J Ophthalmol 2018;66:177-8 |
Sir,
We would like to call your attention to the article titled, “Impact of expansion of telemedicine screening for retinopathy of prematurity (ROP) in India” recently published in Indian Journal of Ophthalmology.[1]
There has been an underestimation in the expected treatment-requiring ROP babies in several states of India in this study.[1]
The incidence of ROP from rural Karnataka's multicenter study (KIDROP) is 22.39% of survived high-risk babies for any stage ROP and 3.57% of survived high-risk babies for treatment-requiring ROP.[2] This study uses this data to calculate the incidence of treatment- requiring ROP in the ten states but has taken 3.57% of those with any stage ROP and not the survived high-risk babies requiring screening.
The result of this study shows that the total population in the ten study states is 681.5 million. The eligible babies for ROP screening annually are 467,664. The number of babies admitted to neonatal units is 188,561, of which 160,277 are likely to survive and require screening.[1] Based on the KIDROP data,[2] ROP would develop in 35,886 of these infants, and 5722 (and not 1281) babies would require the treatment annually. The fiscal quantum of “blind person-years” saved in these ten states will be far higher than USD 108.4 million annually, reported in this study.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References | | |
1. | Vinekar A, Mangalesh S, Jayadev C, Gilbert C, Dogra M, Shetty B, et al. Impact of expansion of telemedicine screening for retinopathy of prematurity in India. Indian J Ophthalmol 2017;65:390-5. [ PUBMED] [Full text] |
2. | Vinekar A, Jayadev C, Mangalesh S, Shetty B, Vidyasagar D. Role of telemedicine in retinopathy of prematurity screening in rural outreach centers in India-A report of 20,214 imaging sessions in the KIDROP program. Semin Fetal Neonatal Med 2015;20:335-45. [ PUBMED] |
This article has been cited by | 1 |
Outcomes and Complications of Pars Plana Vitrectomy for Tractional Retinal Detachment in People With Diabetes |
|
| Philip McCullough, Ajay Mohite, Gianni Virgili, Noemi Lois | | JAMA Ophthalmology. 2023; | | [Pubmed] | [DOI] | | 2 |
Advances in the tools and techniques of vitreoretinal surgery |
|
| Ashish Markan, Aman Kumar, Jayesh Vira, Vishali Gupta, Aniruddha Agarwal | | Expert Review of Ophthalmology. 2020; 15(6): 331 | | [Pubmed] | [DOI] | | 3 |
Response to comment on “Impact of expansion of telemedicine screening for retinopathy of prematurity in India” |
|
| Anand Vinekar, Shwetha Mangalesh, Chaitra Jayadev, Clare Gilbert, Mangat Dogra, Bhujang Shetty | | Indian Journal of Ophthalmology. 2018; 66(1): 178 | | [Pubmed] | [DOI] | |
|
|
|
|